HG106, recently known as a potent SLC7A11 inhibitor, also showed marked tumor suppression and prolonged survival in the preclinical mouse models of KRAS-mutated lung adenocarcinoma [51]. The gene discussed is KRAS; the disease is lung adenocarcinoma.